Wire report
British people don’t trust Palantir – it’s not too late to reverse the NHS’s dependence on it | Ben Coleman
We can’t allow our health data to be locked into the control of a US tech firm. It won’t be easy, but next spring the job of clawing it back must begin Ben Coleman is Labour MP for Chelsea and Fulham and a member of the health and social care committee Next March, Palantir’s £330m contract to run NHS England’s federated data platform (FDP) ends. Ministers must decide by Christmas whether to extend it. They should move on from Palantir, and transition to new suppliers that put the NHS in full control of its technology and patient data. I sit on the health and social care committee. In June, we recommended no extension – people don’t trust Palantir , its benefits are contested and other tools could deliver the same or similar advantages. The debate so far has been whether to drop Palantir. The harder question is what replaces it. The tempting solution is to hire a single British firm. But
coverage / Wire report
Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.
We can’t allow our health data to be locked into the control of a US tech firm. It won’t be easy, but next spring the job of clawing it back must begin Ben Coleman is Labour MP for Chelsea and Fulham and a member of the health and social care committee Next March, Palantir’s £330m contract to run NHS England’s federated data platform (FDP) ends. Ministers must decide by Christmas whether to extend it. They should move on from Palantir, and transition to new suppliers that put the NHS in full control of its technology and patient data. I sit on the health and social care committee. In June, we recommended no extension – people don’t trust Palantir , its benefits are contested and other tools could deliver the same or similar advantages. The debate so far has been whether to drop Palantir. The harder question is what replaces it. The tempting solution is to hire a single British firm. But
Check the original link, updates, and responses when a detail is contested.
Open topic or search related wording such as records, sources, agencies, dates, and locations.
What happened
According to The Guardian’s source item, British people don’t trust Palantir – it’s not too late to reverse the NHS’s dependence on it | Ben Coleman, We can’t allow our health data to be locked into the control of a US tech firm. It won’t be easy, but next spring the job of clawing it back must begin Ben Coleman is Labour MP for Chelsea and Fulham and a member of the health and social care committee Next March, Palantir’s £330m contract to run NHS England’s federated data platform (FDP) ends. Ministers must decide by Christmas whether to extend it. They should move on from Palantir, and transition to new suppliers that put the NHS in full control of its technology and patient data. I sit on the health and social care committee. In June, we recommended no extension – people don’t trust Palantir , its benefits are contested and other tools could deliver the same or similar advantages. The debate so far has been whether to drop Palantir. The harder question is what replaces it. The tempting solution is to hire a single British firm. But
Context
The development sits in VINI’s Technology file for readers following technology, science, product policy, markets, infrastructure, and the public consequences of innovation. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-11-09T06:00:02+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: British people don’t trust Palantir – it’s not too late to reverse the NHS’s dependence on it | Ben Coleman via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
Keep following
This file can keep developing
vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.
Support and subscriptions never buy coverage, placement, suppression, or corrections.
This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.
Source links
- British people don’t trust Palantir – it’s not too late to reverse the NHS’s dependence on it | Ben ColemanThe Guardian - 2026-11-09T06:00:02+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.
No approved comments yet.
Substantive, civil comments can be submitted by approved account holders.